Ibnsina Pharma (CASE: ISPH)
Health Care · Health Care Providers & Services · EG
EGP11.70
+0.26% today · +3.1% 1Y
Ibnsina Pharma (CASE: ISPH) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $225.28M.
Over the last twelve months the share price has gained 3.1%, trading between 9.63 and 16.93.
Tweenvest scores Ibnsina Pharma across four factors: quality 49/100, value 63/100, growth 94/100, dividend 71/100. Its strongest factor is growth.
ISPH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $225.28M
- Revenue (TTM)
- $1.69B
- P/E
- 13.55
- EPS
- 0.86
- Dividend yield
- 1.37%
- Beta (5Y)
- 0.68
- 52-week high
- EGP16.93
- 52-week low
- EGP9.63
- Avg volume (3M)
- —
- Shares outstanding
- 1.01B
- Employees
- —
- Next earnings
- —
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Value HR Co.,Ltd.TSE: 6078 | $255.31M | ¥1,510.00 | +0.53% |
| PT Multi Medika Internasional TbkIDX: MMIX | $246.77M | Rp920.00 | +3.37% |
| Amvis Holdings, Inc.TSE: 7071 | $237.48M | ¥382.00 | -3.54% |
| Medi Assist Healthcare Services LimitedNSEI: MEDIASSIST | $231.60M | Rs298.50 | -6.68% |
| Wuhan Dazhong Dental Medical Co., Ltd.SEHK: 2651 | $224.31M | HK$29.00 | -1.63% |
| Alexandria New Medical CenterCASE: AMES | $217.72M | EGP46.60 | -4.90% |
| Oncoclínicas do Brasil Serviços Médicos S.A.BOVESPA: ONCO3 | $216.61M | R$1.01 | -3.81% |
| Global Asset Management Group, Inc.OTCPK: GAMG | $216.04M | $0.49 | +8.87% |
Figures last refreshed Oct 4, 2026.